The grants have been the source of new treatments for cancer, heart disease, diabetes, strokes and H.I.V.; wonder drugs like ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

About 69 percent of U.S. counties do not have a gastroenterologist, according to a research letter published online Feb. 6 in ...

It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

U.S. President Donald Trump's administration needs to speed up generic drug approvals and exempt some drugs from funding ...

Manufacturers of medicines, including Pfizer and Eli Lilly, have spent a combined $450,000 lobbying against price caps on ...

So how do we know what these investors just did? Today, Benzinga's options scanner spotted 8 uncommon options trades for Teva Pharmaceutical Indus. This isn't normal. The overall sentiment of ...

US companies eagerly offshored their supply chains to drive down costs and boost profits. But today, the world economy is a ...

One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure ...

The FDA is already limited in policing claims of health benefits by makers of supplements and herbal remedies — a $70 billion ...

Trump signed an executive order establishing the President’s Make America Healthy Again Commission. Robert F. Kennedy Jr. will chair it.